https://drtalk-oncology.simplecast.com 2026-06-12 1 https://drtalk-oncology.simplecast.com/episodes 2026-06-12 0.9 https://drtalk-oncology.simplecast.com/episodes/ascoltaci-nsclc-come-cambia-il-concetto-di-oncogene-addiction-kADPRL2s 2026-06-12 0.8 https://drtalk-oncology.simplecast.com/episodes/ascoltaci-tumori-testa-collo-lera-del-refinement-e-delloncologia-globale-beDDLots 2026-06-11 0.8 https://drtalk-oncology.simplecast.com/episodes/ascoltaci-mtnbc-in-prima-linea-best-first-di4sJlE7 2026-06-08 0.8 https://drtalk-oncology.simplecast.com/episodes/ascoltaci-adenocarcinoma-pancreatico-lalba-di-una-rivoluzione-fg6dZ5iw 2026-06-01 0.8 https://drtalk-oncology.simplecast.com/episodes/ascoltaci-algoritmo-post-cdk4-6i-la-biologia-propone-la-clinica-dispone-6bA_d2Qo 2026-05-30 0.8 https://drtalk-oncology.simplecast.com/episodes/adc-nel-tnbc-e-hr-uno-sguardo-al-futuro-yU5fNzYM 2025-09-17 0.8 https://drtalk-oncology.simplecast.com/episodes/limportanza-della-qualita-di-vita-qrkNkw4Y 2025-07-09 0.8 https://drtalk-oncology.simplecast.com/episodes/la-gestione-della-paziente-anziana-0wzo8xcl 2025-07-04 0.8 https://drtalk-oncology.simplecast.com/episodes/limportanza-degli-studi-real-world-nel-mbc-7_rbiARM 2025-06-23 0.8 https://drtalk-oncology.simplecast.com/episodes/la-rivoluzione-farmacologica-degli-adc-nello-scenario-del-carcinoma-mammario-metastatico-XnRjUJxZ 2025-06-23 0.8 https://drtalk-oncology.simplecast.com/episodes/carcinomi-cutanei-cambiare-strategia-e-una-questione-di-pelle-2fZssjoJ 2025-07-01 0.8 https://drtalk-oncology.simplecast.com/episodes/conoscenza-tempestivita-e-gestione-vento-a-favore-per-chi-sa-governare-FJ7NcX39 2025-06-16 0.8 https://drtalk-oncology.simplecast.com/episodes/il-vino-migliore-si-serve-allinizio-o-alla-fine-del-pasto-oSuOEzRY 2025-06-09 0.8 https://drtalk-oncology.simplecast.com/episodes/tumori-gastrointestinali-e-immunoterapia-4IKbuers 2025-06-04 0.8 https://drtalk-oncology.simplecast.com/episodes/un-incontro-a-chicago-che-combinazione-EA5o9gb0 2025-06-03 0.8 https://drtalk-oncology.simplecast.com/episodes/algoritmi-in-corsia-intelligenze-artificiali-decisioni-umane-eNF9gDhv 2025-06-03 0.8 https://drtalk-oncology.simplecast.com/episodes/adc-gestione-degli-effetti-collaterali-nel-tumore-della-mammella-triplo-negativo-e-hr-metastatico-AMe_SBbc 2025-05-27 0.8 https://drtalk-oncology.simplecast.com/episodes/il-ruolo-degli-adc-nel-tumore-della-mammella-hr-metastatico-TbU_nMWk 2025-05-21 0.8 https://drtalk-oncology.simplecast.com/episodes/il-ruolo-degli-adc-nel-tnbc-iYTALA6C 2025-05-26 0.8 https://drtalk-oncology.simplecast.com/episodes/trapianto-di-fegato-FiEnfAfE 2024-04-08 0.8 https://drtalk-oncology.simplecast.com/episodes/la-nuova-frontiera-dellimmunoterapia-GyqfLCXV 2024-02-09 0.8 https://drtalk-oncology.simplecast.com/episodes/vantaggi-ambulatorio-condiviso-hCV2wxYs 2024-01-24 0.8 https://drtalk-oncology.simplecast.com/episodes/pazienti-anziani-e-comorbidita-nellhcc-i04O4nFq 2023-12-19 0.8 https://drtalk-oncology.simplecast.com/episodes/safety-a-confronto-tra-gli-studi-monarch-DqF8LcNK 2023-12-19 0.8 https://drtalk-oncology.simplecast.com/episodes/i-diritti-del-paziente-iMZAKM71 2023-12-19 0.8 https://drtalk-oncology.simplecast.com/episodes/le-interazioni-farmacologiche-dei-cdk4-6-PvrxT9Yo 2023-12-18 0.8 https://drtalk-oncology.simplecast.com/episodes/la-relazione-con-gli-altri-Ezx0ksDz 2023-12-14 0.8 https://drtalk-oncology.simplecast.com/episodes/tumori-del-fegato-non-hcc-9xKJRkbt 2023-12-05 0.8 https://drtalk-oncology.simplecast.com/episodes/scienza-e-non-solo-RFBXzk_3 2023-12-01 0.8 https://drtalk-oncology.simplecast.com/episodes/due-congressi-ponte-KR4BmMN6 2023-12-01 0.8 https://drtalk-oncology.simplecast.com/episodes/gestione-della-malattia-epatica-e-oncologica-AXDeNJCF 2023-11-28 0.8 https://drtalk-oncology.simplecast.com/episodes/limpatto-di-un-corretto-stile-di-vita-sulle-pazienti-zvJftPs8 2023-11-27 0.8 https://drtalk-oncology.simplecast.com/episodes/sequenze-terapeutiche-Os0_oBUt 2023-11-17 0.8 https://drtalk-oncology.simplecast.com/episodes/trait-dunion-il-lavoro-di-squadra-JoKCJ7p0 2023-11-15 0.8 https://drtalk-oncology.simplecast.com/episodes/carcinoma-della-mammella-le-terapie-mediche-bNMLKOsv 2023-11-09 0.8 https://drtalk-oncology.simplecast.com/episodes/terapia-farmacologica-KfWKETqn 2023-11-08 0.8 https://drtalk-oncology.simplecast.com/episodes/monarch-2-dai-primi-dati-ad-oggi-tiSTYhig 2023-10-09 0.8 https://drtalk-oncology.simplecast.com/episodes/il-ruolo-della-chirurgia-lXIdzwpu 2023-10-05 0.8 https://drtalk-oncology.simplecast.com/episodes/carcinoma-mammario-hr-her2-cdk4-6-e-gestione-della-paziente-VN_GTKtg 2023-09-28 0.8 https://drtalk-oncology.simplecast.com/episodes/il-ruolo-della-radiologia-NZpIW5TB 2023-10-24 0.8 https://drtalk-oncology.simplecast.com/episodes/un-lavoro-di-squadra-hIQ8oUKQ 2023-09-21 0.8 https://drtalk-oncology.simplecast.com/episodes/monarch-3-dati-promettenti-dalla-interim-analysis-I3b_bIjl 2023-09-06 0.8 https://drtalk-oncology.simplecast.com/episodes/diagnosi-di-hcc-sorveglianza-e-marcatori-TwSrvl65 2023-09-05 0.8 https://drtalk-oncology.simplecast.com/episodes/hcc-prevenzione-e-stile-di-vita-ABBo8obN 2023-08-02 0.8 https://drtalk-oncology.simplecast.com/episodes/fattori-di-rischio-dellhcc-Qc6fiFYf 2023-07-27 0.8 https://drtalk-oncology.simplecast.com/episodes/tumore-hr-her2-valutazione-del-rischio-e-terapie-sempre-piu-mirate-9mgAcZff 2023-07-27 0.8 https://drtalk-oncology.simplecast.com/episodes/monarch-e-abemaciclib-nel-trattamento-di-ebc-her2-ad-alto-rischio-di-recidiva-_L9eyGjs 2023-07-11 0.8 https://drtalk-oncology.simplecast.com/episodes/lassociazione-con-abemaciclib-nel-carcinoma-mammario-rCNxUOeM 2023-06-28 0.8 https://drtalk-oncology.simplecast.com/episodes/un-caso-clinico-di-terapia-personalizzata-ExFSkf0o 2023-02-22 0.8 https://drtalk-oncology.simplecast.com/episodes/modelli-organizzativi-e-buone-pratiche-per-la-gestione-del-paziente-uuJXqShs 2022-12-22 0.8 https://drtalk-oncology.simplecast.com/episodes/la-gestione-delle-tossicita-ZFhChX6H 2022-12-21 0.8 https://drtalk-oncology.simplecast.com/episodes/il-ruolo-del-radioterapista-nel-team-multidisciplinare-gdK9VZo4 2022-10-13 0.8 https://drtalk-oncology.simplecast.com/episodes/nsclc-efficacia-di-atezolizumab-nel-paziente-over-70-tvwS_HNn 2022-04-27 0.8 https://drtalk-oncology.simplecast.com/episodes/efficacia-di-atezolizumab-in-seconda-linea-nel-paziente-fragile-22AsJK6J 2022-04-13 0.8 https://drtalk-oncology.simplecast.com/episodes/sclc-dallimmunoterapia-un-nuovo-paradigma-di-trattamento-fCLLmP8z 2022-03-30 0.8 https://drtalk-oncology.simplecast.com/episodes/alectinib-e-qualita-di-vita-una-nuova-speranza-qkZAt5q_ 2022-02-15 0.8 https://drtalk-oncology.simplecast.com/episodes/gestione-degli-effetti-collaterali-di-alpelisib-la-curva-di-apprendimento-U_2_ZXcl 2021-12-23 0.8 https://drtalk-oncology.simplecast.com/episodes/il-ruolo-dei-cdk4-6-inhibitor-e-la-pathway-di-pi3k-R90tjMLg 2021-12-23 0.8 https://drtalk-oncology.simplecast.com/episodes/trial-clinici-i-dati-di-efficacia-e-safety-di-alpelisib-sYzeIMxb 2021-12-23 0.8 https://drtalk-oncology.simplecast.com/episodes/i-risultati-del-solar-1-nel-gruppo-testato-con-ctdna-con-ngs-mk3fDuqy 2021-12-23 0.8 https://drtalk-oncology.simplecast.com/episodes/diagnosi-quali-sono-i-tempi-giusti-ZSfiX5Kc 2021-12-23 0.8 https://drtalk-oncology.simplecast.com/episodes/entrectinib-una-nuova-terapia-di-prima-linea-per-i-nsclc-ros1-positivi-un0H9Fm_ 2021-12-03 0.8 https://drtalk-oncology.simplecast.com/episodes/alk-nella-real-world-practice-un-caso-clinico-emblematico-6GHmwasJ 2021-12-03 0.8 https://drtalk-oncology.simplecast.com/episodes/le-traslocazioni-di-ret-come-esempio-di-medicina-personalizzata-nel-nsclc-UmRyBhRx 2021-07-22 0.8 https://drtalk-oncology.simplecast.com/episodes/covid-19-dalla-prioritizzazione-del-test-alla-vaccinazione-del-paziente-oncologico-_b7baJ_r 2021-07-15 0.8 https://drtalk-oncology.simplecast.com/episodes/checkmate-9la-limmunoterapia-in-combinazione-diventa-il-backbone-qLpWYAZC 2021-06-30 0.8 https://drtalk-oncology.simplecast.com/episodes/disequita-regionali-ojrI_sN_ 2021-06-11 0.8 https://drtalk-oncology.simplecast.com/episodes/disequita-in-italia-test-genomici-e-terapie-di-supporto-a8_tlCbK 2021-06-08 0.8 https://drtalk-oncology.simplecast.com/episodes/telemedicina-ed-equita-una-realta-a-due-facce-a0xvZrPk 2021-06-05 0.8 https://drtalk-oncology.simplecast.com/episodes/determinanti-socioculturali-della-disequita-in-europa-e-in-italia-vsknVitX 2021-06-05 0.8 https://drtalk-oncology.simplecast.com/episodes/equita-nella-ricerca-j2nSeEun 2021-06-04 0.8 https://drtalk-oncology.simplecast.com/episodes/la-mutazione-del-gene-pik3ca-nel-tumore-della-mammella-eNImJEKI 2021-05-21 0.8 https://drtalk-oncology.simplecast.com/episodes/breast-cancer-hr-her2-the-pik3ca-series-8pwAhyQm 2021-05-21 0.8 https://drtalk-oncology.simplecast.com/episodes/terapia-di-supporto-nei-pazienti-con-sclc-feVWroIx 2021-03-02 0.8 https://drtalk-oncology.simplecast.com/episodes/atezolizumab-piu-chemioterapia-un-passo-avanti-nel-trattamento-del-microcitoma-avanzato-w2wyfrwH 2021-02-15 0.8 https://drtalk-oncology.simplecast.com/episodes/il-pdta-in-oncologia-polmonare-_kV1VwoS 2020-12-10 0.8 https://drtalk-oncology.simplecast.com/episodes/aspetti-di-farmaco-economia-xiWe392V 2020-12-10 0.8 https://drtalk-oncology.simplecast.com/episodes/radioterapia-di-consolidamento-toracica-e-pci-nelles-sclc-gVfrr2rm 2020-12-10 0.8 https://drtalk-oncology.simplecast.com/episodes/nuove-molecole-in-sviluppo-e-nuovi-target-terapeutici-nello-sclc-uno-sguardo-al-futuro-_C8fovwG 2020-09-18 0.8 https://drtalk-oncology.simplecast.com/episodes/multidisciplinarieta-nella-gestione-degli-eventi-avversi-immuno-mediati-nel-carcinoma-polmonare-ltEey5n1 2020-09-22 0.8 https://drtalk-oncology.simplecast.com/episodes/nuove-alternative-terapeutiche-nello-sclc-approvata-la-prima-immunoterapia-Qy4hCdUW 2020-07-15 0.8 https://drtalk-oncology.simplecast.com/episodes/es-sclc-hot-topics-part-2-cis-o-carbo-in-associazione-a-immunoterapia-APMh_4Ta 2020-06-22 0.8 https://drtalk-oncology.simplecast.com/episodes/es-sclc-hot-topics-part-1-4-o-6-cicli-di-chemioterapia-yCLEJLF5 2020-06-22 0.8 https://drtalk-oncology.simplecast.com/episodes/il-trattamento-dello-sclc-in-stadio-limitato-UYJuGBRK 2020-06-11 0.8 https://drtalk-oncology.simplecast.com/episodes/sclc-e-nsclc-gestione-del-paziente-da-parte-di-oncologo-e-team-multidisciplinare-KK8cZqqn 2020-06-04 0.8 https://drtalk-oncology.simplecast.com/episodes/stadiazione-del-sclc-oggi-valg-vs-tnm-8th-d9x2bttE 2020-06-04 0.8 https://drtalk-oncology.simplecast.com/episodes/resistenza-e-iperprogressione-allimmunoterapia-nel-nsclc-problemi-e-prospettive-YcIsEKbC 2021-01-25 0.8 https://drtalk-oncology.simplecast.com/episodes/sclc-epidemiologia-eziologia-cosa-ce-di-nuovo-2AKAqn06 2020-06-04 0.8